Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001520138-21-000612
Filing Date
2021-10-08
Accepted
2021-10-08 14:59:23
Documents
1
Period of Report
2021-08-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3919
  Complete submission text file 0001520138-21-000612.txt   5387
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
READING CHRISTOPHER (Reporting) CIK: 0001239658 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39015 | Film No.: 211315116

Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations